NovaBridge Biosciences (NBP) Change in Accured Expenses (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Change in Accured Expenses of $10.7 million for Q4 2025, up 423.15% year-on-year from $2.0 million in Q4 2024, and up 23.96% on a QoQ basis from $8.6 million in Q3 2025.
NovaBridge Biosciences (NBP) Change in Accured Expenses (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Change in Accured Expenses for 4 consecutive years, with $10.7 million the latest figure, recorded in Q4 2025.
- Quarterly Change in Accured Expenses rose 423.15% year-over-year to $10.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.8 million (down 38.33% YoY) and the FY2025 annual result came in at $18.1 million, up 8588.73% from the prior year.
- Change in Accured Expenses grew to $10.7 million in Q4 2025 per NBP's latest filing, from $8.6 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for NBP reached as high as $10.7 million in Q4 2025 and fell as low as -$3.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | -16.74 Mn |
| 10 | NovaBridge Biosciences | 406.38 Mn | 406.38 Mn | - | 10.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.71 Mn |
| Dec 31, 2025 | 10.71 Mn |
| Sep 30, 2025 | 8.64 Mn |
| Sep 30, 2025 | 8.64 Mn |
| Dec 31, 2024 | -3.31 Mn |
| Dec 31, 2024 | -3.31 Mn |
| Sep 30, 2024 | -240,000.00 |
| Sep 30, 2024 | -240,000.00 |
| Dec 31, 2020 | 28.87 Mn |
| Dec 31, 2020 | 28.87 Mn |
| Sep 30, 2020 | 284,190.23 |
| Sep 30, 2020 | 284,190.23 |
| Dec 31, 2019 | 22.16 Mn |
| Dec 31, 2019 | 22.16 Mn |